TipRanks
Little Green Pharma Ltd. (AU:LGP)
ASX:LGP
Australian Market
Want to see AU:LGP full AI Analyst Report?

Little Green Pharma Ltd. (LGP) Ratios

20 Followers

Little Green Pharma Ltd. Ratios

AU:LGP's free cash flow for Q4 2026 was AU$0.29. For the 2026 fiscal year, AU:LGP's free cash flow was decreased by AU$ and operating cash flow was AU$-0.03. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Mar 24Mar 23
Liquidity Ratios
Current Ratio
3.48 3.48 2.60 ― 2.82
Quick Ratio
1.16 1.16 1.02 ― 2.01
Cash Ratio
0.20 0.20 0.27 ― 1.12
Solvency Ratio
0.22 0.22 0.63 ― -0.38
Operating Cash Flow Ratio
<0.01 <0.01 -0.10 ― -0.63
Short-Term Operating Cash Flow Coverage
0.03 0.03 -0.40 ― -1.06
Net Current Asset Value
AU$ 13.76MAU$ 13.76MAU$ 11.61MAU$ ―AU$ 14.75M
Leverage Ratios
Debt-to-Assets Ratio
0.05 0.05 0.05 ― 0.12
Debt-to-Equity Ratio
0.06 0.06 0.05 ― 0.14
Debt-to-Capital Ratio
0.05 0.05 0.05 ― 0.13
Long-Term Debt-to-Capital Ratio
0.03 0.03 <0.01 ― 0.06
Financial Leverage Ratio
1.13 1.13 1.13 ― 1.20
Debt Service Coverage Ratio
1.47 1.09 2.77 ― -1.20
Interest Coverage Ratio
-3.54 -3.54 -10.54 ― -8.21
Debt to Market Cap
0.16 0.12 0.08 ― 0.26
Interest Debt Per Share
0.02 0.02 0.02 ― 0.05
Net Debt to EBITDA
1.29 1.77 -3.35 ― 0.11
Profitability Margins
Gross Profit Margin
27.65%27.65%68.59%―61.21%
EBIT Margin
-3.00%-4.62%-11.97%―-38.98%
EBITDA Margin
5.98%4.36%-1.86%―-23.73%
Operating Profit Margin
-4.62%-4.62%-11.00%―-38.98%
Pretax Profit Margin
-3.64%-3.64%-13.01%―-43.73%
Net Profit Margin
-3.32%-3.32%9.03%―-47.04%
Continuous Operations Profit Margin
-3.32%-3.32%9.03%―0.00%
Net Income Per EBT
91.19%91.19%-69.37%―107.58%
EBT Per EBIT
78.82%78.82%118.35%―112.18%
Return on Assets (ROA)
-1.50%-1.50%3.46%―-9.33%
Return on Equity (ROE)
-1.67%-1.70%3.91%―-11.19%
Return on Capital Employed (ROCE)
-2.26%-2.26%-4.63%―-8.71%
Return on Invested Capital (ROIC)
-2.03%-2.03%3.13%―-8.10%
Return on Tangible Assets
-1.56%-1.56%3.62%―-9.69%
Earnings Yield
-6.39%-4.76%8.80%―-20.47%
Efficiency Ratios
Receivables Turnover
6.97 6.97 9.29 ― 2.65
Payables Turnover
9.93 9.93 2.94 ― 2.26
Inventory Turnover
1.88 1.88 0.84 ― 0.85
Fixed Asset Turnover
0.75 0.75 0.61 ― 0.31
Asset Turnover
0.45 0.45 0.38 ― 0.20
Working Capital Turnover Ratio
2.49 2.70 2.64 ― 1.00
Cash Conversion Cycle
210.10 210.10 351.59 ― 404.78
Days of Sales Outstanding
52.33 52.33 39.30 ― 137.69
Days of Inventory Outstanding
194.51 194.51 436.45 ― 428.42
Days of Payables Outstanding
36.74 36.74 124.16 ― 161.34
Operating Cycle
246.84 246.84 475.75 ― 566.11
Cash Flow Ratios
Operating Cash Flow Per Share
<0.01 <0.01 >-0.01 ― -0.03
Free Cash Flow Per Share
>-0.01 >-0.01 >-0.01 ― -0.05
CapEx Per Share
<0.01 <0.01 <0.01 ― 0.02
Free Cash Flow to Operating Cash Flow
-20.26 -20.26 1.26 ― 1.71
Dividend Paid and CapEx Coverage Ratio
0.05 0.05 -0.22 ― -0.65
Capital Expenditure Coverage Ratio
0.05 0.05 -3.87 ― -1.41
Operating Cash Flow Coverage Ratio
<0.01 <0.01 -0.20 ― -0.58
Operating Cash Flow to Sales Ratio
<0.01 <0.01 -0.02 ― -0.35
Free Cash Flow Yield
-3.59%-2.67%-3.05%―-26.39%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-15.65 -21.09 11.36 ― -4.89
Price-to-Sales (P/S) Ratio
0.52 0.70 1.03 ― 2.30
Price-to-Book (P/B) Ratio
0.27 0.36 0.44 ― 0.55
Price-to-Free Cash Flow (P/FCF) Ratio
-27.82 -37.45 -32.74 ― -3.79
Price-to-Operating Cash Flow Ratio
564.66 758.71 -41.20 ― -6.48
Price-to-Earnings Growth (PEG) Ratio
-0.04 0.15 -0.08 ― 0.08
Price-to-Fair Value
0.27 0.36 0.44 ― 0.55
Enterprise Value Multiple
9.96 17.77 -58.59 ― -9.57
Enterprise Value
25.25M 32.86M 40.07M ― 44.44M
EV to EBITDA
9.96 17.77 -58.59 ― -9.57
EV to Sales
0.60 0.77 1.09 ― 2.27
EV to Free Cash Flow
-31.96 -41.60 -34.73 ― -3.74
EV to Operating Cash Flow
647.40 842.64 -43.70 ― -6.40
Tangible Book Value Per Share
0.26 0.26 0.27 ― 0.31
Shareholders’ Equity Per Share
0.27 0.27 0.28 ― 0.33
Tax and Other Ratios
Effective Tax Rate
0.09 0.09 1.69 ― -0.51
Revenue Per Share
0.14 0.14 0.12 ― 0.08
Net Income Per Share
>-0.01 >-0.01 0.01 ― -0.04
Tax Burden
0.91 0.91 -0.69 ― 1.08
Interest Burden
1.21 0.79 1.09 ― 1.12
Research & Development to Revenue
<0.01 <0.01 <0.01 ― 0.34
SG&A to Revenue
0.24 0.51 0.61 ― 0.24
Stock-Based Compensation to Revenue
0.00 0.00 0.07 ― 0.12
Income Quality
-0.03 -0.03 -0.28 ― 0.81
Currency in AUD